Last 7 days
2.0%
Last 30 days
-13.9%
Last 90 days
-5.3%
Trailing 12 Months
-64.1%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-16 | Dubovsky Filip | acquired | 97,485 | 7.71 | 12,644 | president, r&d |
2023-09-16 | Dubovsky Filip | sold (taxes) | -47,092 | 7.71 | -6,108 | president, r&d |
2023-08-19 | Trizzino John | sold (taxes) | -2,263 | 7.14 | -317 | evp, cco and cbo |
2023-08-19 | Trizzino John | acquired | - | - | 655 | evp, cco and cbo |
2023-08-16 | Kelly James Patrick | sold (taxes) | -8,149 | 7.13 | -1,143 | evp, cfo and treasurer |
2023-08-16 | Kelly James Patrick | acquired | - | - | 2,366 | evp, cfo and treasurer |
2023-06-25 | Trizzino John | sold (taxes) | -2,700 | 6.7 | -403 | evp, cco and cbo |
2023-06-25 | Trizzino John | acquired | - | - | 833 | evp, cco and cbo |
2023-06-25 | Herrmann John A III | acquired | - | - | 833 | evp, chief legal officer |
2023-06-25 | Herrmann John A III | sold (taxes) | -1,862 | 6.7 | -278 | evp, chief legal officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-09-21 | Jefferies Group LLC | new | - | 1,274 | 1,274 | -% |
2023-09-20 | BARCLAYS PLC | added | 15.73 | 780,000 | 4,023,000 | -% |
2023-09-12 | Farther Finance Advisors, LLC | reduced | -16.67 | -9.00 | 74.00 | -% |
2023-08-22 | Asset Dedication, LLC | unchanged | - | - | - | -% |
2023-08-22 | COMERICA BANK | new | - | - | - | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | added | 55.79 | 381,344 | 950,297 | 0.01% |
2023-08-21 | OSAIC HOLDINGS, INC. | added | 18.53 | 120,875 | 564,727 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 3.66 | 78,002 | 778,486 | -% |
2023-08-16 | Sunbelt Securities, Inc. | unchanged | - | 8.00 | 74.00 | -% |
2023-08-16 | Nuveen Asset Management, LLC | reduced | -16.95 | -229,667 | 1,868,330 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Aug 18, 2023 | sk bioscience co., ltd. | 6.4% | 6,500,000 | SC 13G | |
May 10, 2023 | state street corp | 12.11% | 10,452,512 | SC 13G/A | |
Apr 27, 2023 | shah capital management | 5.28% | 4,550,756 | SC 13D | |
Feb 09, 2023 | vanguard group inc | 10.41% | 8,844,653 | SC 13G/A | |
Feb 02, 2023 | state street corp | 7.15% | 6,076,518 | SC 13G/A | |
Feb 01, 2023 | blackrock inc. | 5.7% | 4,808,261 | SC 13G/A | |
Mar 11, 2022 | blackrock inc. | 5.8% | 4,410,761 | SC 13G/A | |
Feb 14, 2022 | ra capital management, l.p. | 2.8% | 2,097,794 | SC 13G/A | |
Feb 08, 2022 | blackrock inc. | 5.8% | 4,410,761 | SC 13G | |
Feb 16, 2021 | ra capital management, l.p. | 6.0% | 3,788,564 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 19, 2023 | 4 | Insider Trading | |
Aug 22, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | 4 | Insider Trading | |
Aug 18, 2023 | SC 13G | Major Ownership Report | |
Aug 08, 2023 | S-8 | Employee Benefits Plan | |
Aug 08, 2023 | 10-Q | Quarterly Report | |
Aug 08, 2023 | 424B5 | Prospectus Filed | |
Aug 08, 2023 | 8-K | Current Report | |
Aug 08, 2023 | 8-K | Current Report | |
Aug 08, 2023 | 8-K | Current Report |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
AMGN | 143.9B | 26.6B | 4.85% | 20.90% | 18.03 | 5.41 | 0.75% | 21.34% |
GILD | 94.2B | 27.4B | -1.93% | 22.79% | 17.18 | 3.44 | -0.48% | 32.56% |
MRNA | 37.9B | 10.7B | -12.64% | -18.65% | 31.39 | 3.56 | -53.67% | -91.41% |
BIIB | 37.3B | 10.0B | -2.84% | 30.20% | 13.98 | 3.74 | -6.23% | 29.40% |
MID-CAP | ||||||||
NBIX | 11.3B | 1.7B | 8.03% | 13.91% | 63.88 | 6.74 | 29.01% | 1345.90% |
BBIO | 4.3B | - | -8.13% | 165.26% | -7.28 | 48.33 | 54.84% | -12.96% |
DNLI | 3.0B | - | -5.45% | -21.11% | -23.04 | 37.44 | 122.90% | 54.78% |
BEAM | 1.9B | 80.2M | 3.54% | -49.89% | -5.78 | 23.59 | 42.17% | -39.82% |
SMALL-CAP | ||||||||
RCUS | 1.4B | 121.2M | -13.83% | -27.58% | -4.86 | 11.52 | -70.36% | -531.73% |
REPL | 979.0M | 15.3M | -20.35% | -0.54% | -5.39 | 63.94 | 1090.59% | -36.57% |
NVAX | 678.1M | 1.6B | -13.89% | -64.12% | -1.16 | 0.42 | 23.74% | 60.24% |
FATE | 206.9M | - | -21.05% | -90.40% | -0.98 | 1.51 | 116.83% | 16.61% |
VXRT | 109.6M | 2.1M | -12.14% | -66.77% | -1.09 | 53.32 | 487.70% | -8.66% |
SGMO | 104.5M | - | -28.14% | -88.04% | -0.53 | 0.43 | 113.96% | -15.19% |
IBIO | 3.6M | - | -8.13% | -96.28% | -0.05 | 3.21 | - | -129.46% |
-19.6%
-22.8%
-28.2%
-60.1%
100%
100%
100%
Y-axis is the maximum loss one would have experienced if Novavax was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | ||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Revenue | 17.6% | 1,597,353,000 | 1,358,852,000 | 1,981,872,000 | 1,846,673,000 | 1,290,940,000 | 1,403,032,000 | 1,146,290,000 | 1,203,749,000 | 1,181,929,000 | 919,450,000 | 475,598,000 | 204,755,000 | 50,238,000 | 18,057,000 | 18,662,000 | 15,973,000 | 21,201,000 | 28,617,000 | 34,288,000 | 38,573,000 | 39,190,000 |
Costs and Expenses | -11.9% | 2,225,732,000 | 2,525,648,000 | 2,626,608,000 | 3,072,501,000 | 2,696,723,000 | 2,671,684,000 | 2,832,866,000 | 2,248,207,000 | 2,113,185,000 | 1,521,904,000 | 892,317,000 | 467,326,000 | 133,854,000 | 121,312,000 | 139,243,000 | 154,361,000 | 186,502,000 | 199,245,000 | 208,206,000 | 213,763,000 | 214,108,000 |
S&GA Expenses | -2.9% | 490,788,000 | 505,231,000 | 488,691,000 | 411,242,000 | 366,159,000 | 331,160,000 | 298,358,000 | 275,457,000 | 254,543,000 | 199,101,000 | 145,290,000 | 92,158,000 | 43,178,000 | 35,065,000 | 34,417,000 | 35,461,000 | 35,871,000 | 34,489,000 | 34,409,000 | 33,725,000 | 33,534,000 |
R&D Expenses | -6.4% | 1,028,723,000 | 1,098,896,000 | 1,235,278,000 | 1,940,385,000 | 2,044,283,000 | 2,325,320,000 | 2,534,508,000 | 1,972,750,000 | 1,858,642,000 | 1,322,803,000 | 747,027,000 | 375,168,000 | 99,692,000 | 95,263,000 | 113,842,000 | 127,916,000 | 150,631,000 | 164,756,000 | 173,797,000 | 180,038,000 | 180,574,000 |
EBITDA | 100.0% | - | -1,101,787,000 | -604,713,000 | -1,252,892,000 | -1,406,213,000 | -1,249,250,000 | -1,680,748,000 | -1,033,103,000 | -914,745,000 | -408,196,000 | -409,632,000 | -411,276,000 | -52,755,000 | -138,663,000 | -137,649,000 | - | - | - | - | - | - |
EBITDA Margin | 100.0% | - | -0.56 | -0.31 | -0.68 | -1.09 | -0.89 | -1.47 | -0.86 | -0.77 | -0.44 | -0.86 | -2.01 | -1.05 | -7.68 | -7.38 | - | - | - | - | - | - |
Interest Expenses | -16.1% | 16,210,000 | 19,320,000 | 19,880,000 | 20,417,000 | 21,430,000 | 21,164,000 | 21,127,000 | 19,868,000 | 19,146,000 | 16,581,000 | 15,145,000 | 14,669,000 | 13,612,000 | 13,612,000 | 13,612,000 | 13,612,000 | 13,612,000 | 13,612,000 | 13,612,000 | 13,732,000 | 13,849,000 |
Earnings Before Taxes | 49.2% | -585,507,000 | -1,152,439,000 | -653,647,000 | -1,298,813,000 | -1,449,062,000 | -1,288,764,000 | -1,714,536,000 | -1,062,425,000 | -943,345,000 | -612,097,000 | -418,259,000 | -429,662,000 | -70,084,000 | - | -132,694,000 | - | - | - | - | - | - |
EBT Margin | 100.0% | - | -0.58 | -0.33 | -0.70 | -1.12 | -0.92 | -1.50 | -0.88 | -0.80 | -0.47 | -0.90 | -2.10 | -1.40 | -8.69 | -8.41 | - | - | - | - | - | - |
Net Income | 49.2% | -586,759,000 | -1,155,252,000 | -657,939,000 | -1,321,974,000 | -1,475,792,000 | -1,317,624,000 | -1,743,751,000 | -1,075,031,000 | -949,910,000 | -615,114,000 | -418,259,000 | -272,525,000 | -93,258,000 | -115,340,000 | -132,694,000 | -150,198,000 | -176,725,000 | -181,614,000 | -184,748,000 | -186,257,000 | -186,294,000 |
Net Income Margin | 100.0% | - | -0.58 | -0.33 | -0.72 | -1.14 | -0.94 | -1.52 | -0.89 | -0.80 | -0.67 | -0.88 | -1.33 | -1.86 | -6.39 | -7.11 | - | - | - | - | - | - |
Free Cashflow | 100.0% | - | -653,027,000 | -415,937,000 | -728,573,000 | - | -428,649,000 | 322,946,000 | 536,786,000 | 672,432,000 | 643,654,000 | -42,541,000 | 62,284,000 | 36,522,000 | -109,126,000 | -136,623,000 | -158,146,000 | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Assets | 9.2% | 1,685 | 1,543 | 2,259 | 2,267 | 2,623 | 2,835 | 2,577 | 2,566 | 2,750 | 2,608 | 1,582 | 944 | 932 | 328 | 173 | 165 | 189 | 221 | 208 | 250 | 286 |
Current Assets | 16.1% | 1,128 | 971 | 1,703 | 1,760 | 2,136 | 2,347 | 2,155 | 2,174 | 2,355 | 2,247 | 1,248 | 671 | 636 | 255 | 97.00 | 89.00 | 110 | 123 | 119 | 161 | 194 |
Cash Equivalents | -19.0% | 506 | 625 | 1,337 | 1,281 | 1,388 | 1,584 | 1,528 | 1,947 | 2,123 | 2,029 | 553 | 402 | 532 | 187 | 82.00 | 76.00 | 78.00 | 106 | 82.00 | 75.00 | 100 |
Inventory | -31.3% | 23.00 | 34.00 | 37.00 | 82.00 | 256 | 107 | 9.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net PPE | -2.4% | 300 | 307 | 294 | 256 | 255 | 247 | 226 | 215 | 213 | 192 | 180 | 132 | 115 | 11.00 | 11.00 | 12.00 | 13.00 | 27.00 | 28.00 | 29.00 | 31.00 |
Goodwill | -1.1% | 128 | 130 | 126 | 118 | 123 | 131 | 131 | 132 | 134 | 131 | 135 | 127 | 119 | 50.00 | 51.00 | 50.00 | 51.00 | 51.00 | 52.00 | 52.00 | 52.00 |
Liabilities | 0.1% | 2,440 | 2,438 | 2,893 | 2,833 | 3,040 | 2,770 | 2,928 | 2,105 | 2,004 | 1,569 | 955 | 638 | 548 | 352 | 359 | 355 | 375 | 372 | 376 | 377 | 374 |
Current Liabilities | -16.8% | 1,596 | 1,919 | 2,460 | 1,668 | 2,156 | 2,261 | 2,390 | 1,753 | 1,652 | 1,209 | 580 | 239 | 213 | 19.00 | 26.00 | 22.00 | 41.00 | 31.00 | 46.00 | 47.00 | 43.00 |
Shareholder's Equity | 15.8% | -754 | -895 | -634 | - | -416 | 65.00 | -351 | 461 | 746 | 1,039 | 627 | 106 | 185 | - | - | - | - | - | - | - | - |
Retained Earnings | 1.3% | -4,511 | -4,569 | -4,275 | -4,093 | -3,925 | -3,414 | -3,617 | -2,771 | -2,449 | -2,096 | -1,874 | -1,696 | -1,499 | -1,457 | -1,431 | -1,399 | -1,381 | -1,342 | -1,299 | -1,249 | -1,205 |
Additional Paid-In Capital | 2.3% | 3,856 | 3,768 | 3,738 | 3,641 | 3,605 | 3,566 | 3,352 | 3,311 | 3,237 | 3,180 | 2,535 | 1,849 | 1,699 | 1,450 | 1,261 | 1,226 | 1,211 | 1,202 | 1,145 | 1,133 | 1,127 |
Shares Outstanding | 9.3% | 94.00 | 86.00 | 86.00 | 78.00 | 78.00 | 76.00 | 76.00 | 75.00 | 74.00 | 73.00 | 71.00 | 62.00 | 59.00 | 44.00 | 32.00 | 23.00 | 23.00 | 20.00 | 18.00 | 18.00 | 19.00 |
Cashflow (Last 12 Months) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 |
Cashflow From Operations | -0.2% | -654 | -653 | -415 | -640 | -743 | -428 | 323 | 537 | 672 | 644 | -42.54 | 62.00 | 37.00 | -109 | -136 | -158 | -159 | -169 | -184 | -182 | -193 |
Share Based Compensation | -14.1% | 108 | 126 | 130 | 135 | 148 | 163 | 184 | 202 | 222 | 177 | 128 | 82.00 | 19.00 | 15.00 | 17.00 | 17.00 | 19.00 | 19.00 | 18.00 | 21.00 | 21.00 |
Cashflow From Investing | 16.8% | -82.92 | -99.72 | -92.98 | -87.28 | -69.96 | -58.28 | 100 | 85.00 | -3.12 | -178 | -377 | -346 | -228 | -37.95 | 38.00 | 87.00 | 77.00 | 27.00 | 29.00 | -2.96 | 31.00 |
Cashflow From Financing | 29.9% | -132 | -189 | 325 | 73.00 | 88.00 | 45.00 | 462 | 927 | 920 | 1,376 | 985 | 610 | 645 | 228 | 98.00 | 72.00 | 61.00 | 115 | 103 | 116 | 139 |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenue: | ||||
Revenues | $ 424,426 | $ 185,925 | $ 505,377 | $ 889,896 |
Expenses: | ||||
Cost of sales | 55,777 | 271,077 | 89,863 | 286,281 |
Research and development | 219,475 | 289,648 | 466,576 | 673,131 |
Selling, general, and administrative | 93,717 | 108,160 | 206,249 | 204,152 |
Total expenses | 368,969 | 668,885 | 762,688 | 1,163,564 |
Income (Loss) from operations | 55,457 | (482,960) | (257,311) | (273,668) |
Other income (expense): | ||||
Interest expense | (3,124) | (6,234) | (7,440) | (11,110) |
Other income (expense) | 5,532 | (19,873) | 29,894 | (18,219) |
Income (Loss) before income tax expense (benefit) | 57,865 | (509,067) | (234,857) | (302,997) |
Income tax expense (benefit) | (143) | 1,418 | 1,040 | 4,080 |
Net income (loss) | $ 58,008 | $ (510,485) | $ (235,897) | $ (307,077) |
Earnings Per Share [Abstract] | ||||
Basic (in usd per share) | $ 0.65 | $ (6.53) | $ (2.69) | $ (3.97) |
Diluted (in usd per share) | $ 0.58 | $ (6.53) | $ (2.69) | $ (3.97) |
Weighted average number of common shares outstanding | ||||
Basic (in shares) | 89,362 | 78,143 | 87,769 | 77,305 |
Diluted (in shares) | 104,065 | 78,143 | 87,769 | 77,305 |
Product sales | ||||
Revenue: | ||||
Revenues | $ 285,163 | $ 55,455 | $ 277,706 | $ 641,083 |
Grants | ||||
Revenue: | ||||
Revenues | 137,079 | 107,774 | 224,458 | 207,075 |
Royalties and other | ||||
Revenue: | ||||
Revenues | $ 2,184 | $ 22,696 | $ 3,213 | $ 41,738 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 505,912 | $ 1,336,883 |
Restricted cash | 10,361 | 10,303 |
Accounts receivable | 394,890 | 82,375 |
Inventory | 23,488 | 36,683 |
Prepaid expenses and other current assets | 192,903 | 237,147 |
Total current assets | 1,127,554 | 1,703,391 |
Property and equipment, net | 299,955 | 294,247 |
Right of use asset, net | 95,739 | 106,241 |
Goodwill | 128,366 | 126,331 |
Other non-current assets | 33,434 | 28,469 |
Total assets | 1,685,048 | 2,258,679 |
Current liabilities: | ||
Accounts payable | 87,246 | 216,517 |
Accrued expenses | 458,397 | 591,158 |
Deferred revenue | 300,473 | 370,137 |
Current portion of finance lease liabilities | 953 | 27,196 |
Convertible notes payable | 0 | 324,881 |
Other current liabilities | 749,186 | 930,055 |
Total current liabilities | 1,596,255 | 2,459,944 |
Deferred revenue | 606,937 | 179,414 |
Convertible notes payable | 167,248 | 166,466 |
Non-current finance lease liabilities | 30,744 | 31,238 |
Other non-current liabilities | 38,383 | 55,695 |
Total liabilities | 2,439,567 | 2,892,757 |
Commitments and contingencies (Note 15) | ||
Preferred stock, $0.01 par value, 2,000,000 shares authorized at June 30, 2023 and December 31, 2022; no shares issued and outstanding at June 30, 2023 and December 31, 2022. | 0 | 0 |
Stockholders' deficit: | ||
Common stock, $0.01 par value, 600,000,000 shares authorized at June 30, 2023 and December 31, 2022; 95,183,750 shares issued and 94,308,379 shares outstanding at June 30, 2023 and 86,806,554 shares issued and 86,039,923 shares outstanding at December 31, 2022 | 952 | 868 |
Additional paid-in capital | 3,855,916 | 3,737,979 |
Accumulated deficit | (4,511,786) | (4,275,889) |
Treasury stock, cost basis, 875,371 shares at June 30, 2023 and 766,631 shares at December 31, 2022 | (91,424) | (90,659) |
Accumulated other comprehensive loss | (8,177) | (6,377) |
Total stockholders’ deficit | (754,519) | (634,078) |
Total liabilities and stockholders’ deficit | $ 1,685,048 | $ 2,258,679 |